rac-Enprostil

CAS : 73121-56-9

Ref. 3D-YCA12156

Informations sur le produit

• Nom: rac-Enprostil
• Synonymes: 4,5-Heptadienoic acid, 7-(3-hydroxy-2-(3-hydroxy-4-phenoxy-1-butenyl)-5-oxocyclopentyl)-, methyl ester, 4,5-Heptadienoic acid, 7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3R)-3-hydroxy-4-phenoxy-1-buten-1-yl]-5-oxocyclopentyl]-, methyl ester, rel-, 4,5-Heptadienoic acid, 7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3R)-3-hydroxy-4-phenoxy-1-butenyl]-5-oxocyclopentyl]-, methyl ester, rel-, Camleed, Enprostil [USAN:INN:BAN:JAN], Enprostilo, Enprostilo [Spanish], Enprostilum, Enprostilum [Latin], Fundyl, Gardrin, Gardrine, Methyl 7-((1R*,2R*,3R*)-3-hydroxy-2-((E)-(3R*)-3-hydroxy-4-phenoxy-1-butenyl)-5-oxocyclopentyl)-4,5-heptadienoate, Rs 84-135, Rs 84135, Rs 84135-004, Syngard, methyl 7-{(1R,2R,3R)-3-hydroxy-2-[(1E,3R)-3-hydroxy-4-phenoxybut-1-en-1-yl]-5-oxocyclopentyl}hepta-4,5-dienoate, methyl 7-{(1S,2S,3S)-3-hydroxy-2-[(1Z,3R)-3-hydroxy-4-phenoxybut-1-en-1-yl]-5-oxocyclopentyl}hepta-4,5-dienoate

Description

Rac-Enprostil is a new drug that is being developed to treat diabetic neuropathy. It has a significant clinical relevance as it can be used to regulate the production of prostaglandins in the body and inhibit the development of diabetic neuropathy. Rac-Enprostil has been shown to have an inhibitory effect on spontaneous activity, inflammation, and active substances such as sodium citrate. The drug also has an anti-inflammatory and immune regulatory effect in inflammatory bowel disease, cancer, and autoimmune diseases. Rac-Enprostil is not effective against infectious diseases.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 400.5 g/mol
• Formule: C₂₃H₂₈O₆
• Degré de pureté: Min. 95%